1 results match your criteria: "Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital)[Affiliation]"
Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis.
BMC Gastroenterol
September 2023
Department of Radiophysics and Technology, Shandong First Medical University (Shandong Academy of Medical Sciences), Shandong Institute of Cancer Prevention and Treatment (Shandong Cancer Hospital), Jinan, China.
Background: The prognosis of patients undergoing hepatectomy combined with transarterial chemoembolization (TACE) and TACE alone was examined in order to better understand the role of hepatectomy in the treatment of hepatocellular carcinoma (HCC). In this work, we also created a model and investigated the variables influencing overall survival (OS) in HCC patients.
Methods: Retrospective analysis of 1083 patients who received TACE alone as the control group and 188 patients who received TACE after surgery in a total of 1271 HCC patients treated with LR + TACE or TACE at three third-class hospitals in China.